Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2019 3
2021 4
2022 10
2023 15
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4.
Ghose A, McCann L, Makker S, Mukherjee U, Gullapalli SVN, Erekkath J, Shih S, Mahajan I, Sanchez E, Uccello M, Moschetta M, Adeleke S, Boussios S. Ghose A, et al. Among authors: adeleke s. Ther Adv Med Oncol. 2024 Feb 29;16:17588359241233225. doi: 10.1177/17588359241233225. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 38435431 Free PMC article. Review.
Immune checkpoint inhibitors in patients with cancers of unknown primary.
Rassy E, Karam E, Adeleke S, Okoli S, Galante J, Boussios S, Pavlidis N. Rassy E, et al. Among authors: adeleke s. Eur J Cancer. 2023 Dec;195:113377. doi: 10.1016/j.ejca.2023.113377. Epub 2023 Oct 25. Eur J Cancer. 2023. PMID: 37890352 No abstract available.
The Role of Multiparametric MRI and MRI-targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST Trial.
Light A, Kanthabalan A, Otieno M, Pavlou M, Omar R, Adeleke S, Giganti F, Brew-Graves C, Williams NR, Emara A, Haroon A, Latifoltojar A, Sidhu H, Freeman A, Orczyk C, Nikapota A, Dudderidge T, Hindley RG, Virdi J, Arya M, Payne H, Mitra AV, Bomanji J, Winkler M, Horan G, Moore CM, Emberton M, Punwani S, Ahmed HU, Shah TT. Light A, et al. Among authors: adeleke s. Eur Urol. 2024 Jan;85(1):35-46. doi: 10.1016/j.eururo.2023.09.001. Epub 2023 Sep 29. Eur Urol. 2024. PMID: 37778954 Free article. Clinical Trial.
Gestational Renal Cell Cancer - An Update.
Caglayan A, Rabbani RD, Sanchez E, Choi S, Ismail A, Papadopoulos V, Adeleke S, Ghose A, Boussios S. Caglayan A, et al. Among authors: adeleke s. Anticancer Res. 2023 Sep;43(9):3871-3880. doi: 10.21873/anticanres.16574. Anticancer Res. 2023. PMID: 37648307 Review.
Melanoma-the therapeutic considerations in the clinical practice.
Adeleke S, Okoli S, Augustine A, Galante J, Agnihotri A, Uccello M, Ghose A, Moschetta M, Boussios S. Adeleke S, et al. Ann Palliat Med. 2023 Nov;12(6):1355-1372. doi: 10.21037/apm-22-1432. Epub 2023 Jun 30. Ann Palliat Med. 2023. PMID: 37431221 Free article.
External validation of a risk model predicting failure of salvage focal ablation for prostate cancer.
Light A, Peters M, Reddy D, Kanthabalan A, Otieno M, Pavlou M, Omar R, Adeleke S, Giganti F, Brew-Graves C, Williams NR, Emara A, Haroon A, Latifoltojar A, Sidhu H, Freeman A, Orczyk C, Nikapota A, Dudderidge T, Hindley RG, Virdi J, Arya M, Payne H, Mitra AV, Bomanji J, Winkler M, Horan G, Moore C, Emberton M, Punwani S, Ahmed HU, Shah TT. Light A, et al. Among authors: adeleke s. BJU Int. 2023 Nov;132(5):520-530. doi: 10.1111/bju.16102. Epub 2023 Jun 29. BJU Int. 2023. PMID: 37385981
AI vs FRCR: What it means for the future.
Ranjan A, Parpaleix A, Cardoso J, Adeleke S. Ranjan A, et al. Among authors: adeleke s. Eur J Radiol. 2023 Aug;165:110918. doi: 10.1016/j.ejrad.2023.110918. Epub 2023 Jun 8. Eur J Radiol. 2023. PMID: 37311341 Free article.
33 results